Adult Congenital Heart Association Inc is located in Media, PA. The organization was established in 1999. According to its NTEE Classification (G43) the organization is classified as: Heart & Circulatory System Diseases & Disorders, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2023, Adult Congenital Heart Association Inc employed 18 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Adult Congenital Heart Association Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Adult Congenital Heart Association Inc generated $2.4m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 1.3% each year. All expenses for the organization totaled $2.0m during the year ending 12/2023. While expenses have increased by 0.3% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Adult Congenital Heart Association Inc has awarded 22 individual grants totaling $740,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO EMPOWER THE CHD COMMUNITY BY ADVANCING ACCESS TO RESOURCES AND SPECIALIZED CARE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
ACCREDITATION, SUPPORT, EDUCATION AND AWARENESS ACTIVITIES:-MEDICAL CENTER ACCREDITATION PROGRAM: THE ACCREDITATION PROGRAM STARTED IN 2014. AS OF DECEMBER 2023, THERE ARE A TOTAL OF 50 ACCREDITED SITES IN THE US. THERE ARE SEVERAL ADDITIONAL SITES CURRENTLY IN VARIOUS STAGES OF THE ACCREDITATION PROCESS.-PEER SUPPORT PROGRAM: ACHA MANAGES VOLUNTEERS TO PROVIDE ONE ON ONE SUPPORT TO ACHD PATIENTS SEEKING SUCH HELP.(CONTINUED ON SCHEDULE O).- EDUCATIONAL MATERIALS AND WEBINARS: THROUGH ITS WEBSITE, WEBINARS, AND SOCIAL MEDIA CHANNELS, ACHA PROVIDES 24-HOUR ACCESS TO RELEVANT, UP-TO-DATE INFORMATION AND RESOURCES. FROM THE WEBINARS PATIENTS LEARN MORE ABOUT SPECIFIC CHD CONDITIONS AND DEFECTS, AND THE ISSUES THAT AFFECT THEIR LIVES. LEADING EXPERTS AND ADVOCATES COVER A RANGE OF INTERESTING, DIVERSE, AND TIMELY TOPICS IN PATIENT-FRIENDLY LANGUAGE.- ACHA REGIONAL CONFERENCES: A REGIONAL CONFERENCE WAS HELD IN PERSON (TENNESSEE) DURING 2023. THREE IN-PERSON REGIONAL CONFERENCES ARE CURRENTLY BEING PLANNED FOR 2024. EACH CONFERENCE BEGINS WITH A DYNAMIC PARTNERSHIP WITH PATIENTS, PROFESSIONALS, AND INSTITUTIONS. EACH EVENT IS TAILORED TO REGIONAL NEEDS AND CAN INCLUDE: AN EDUCATIONAL PRESENTATION (TOPICS INCLUDE ACHA 101, ACHD OVERVIEW, DEFECT SPECIFIC INFORMATION, ETC.), GROUP ROUNDTABLES, AND EDUCATION MATERIALS AND RESOURCES. ACHD CARE GUIDELINES ARE REVIEWED AT EVERY SESSION TO ENCOURAGE LIFELONG CARE. - ACHD CLINIC DIRECTORY: ACHA EXPANDED ITS ONLINE LISTING WITH CLOSE TO 400 ACHD CLINICS (INCLUDING SATELLITE CLINICS) IN THE UNITED STATES AND CANADA; THE DIRECTORY CONTINUES TO BE THE ONLY RESOURCE OF ITS KIND AVAILABLE IN THE UNITED STATES.- ACHD PATIENT DIRECTORY: THE ACHA ACHD PATIENT RESOURCE DIRECTORY WENT LIVE IN 2023 AND PROVIDES INFORMATION, RESOURCES, AND TOOLS FOR ACHD PATIENTS WHO MIGHT EXPERIENCE BARRIERS WHEN ACCESSING RECOMMENDED SPECIALIZED CARE. THESE SEARCHABLE RESOURCES ARE PROVIDED TO HELP PATIENTS TAKE AN ACTIVE ROLE IN THEIR CARDIAC CARE. PATIENTS CAN SEARCH FOR TOPICS IN AREAS SUCH AS ACHD/CHD ORGANIZATIONS, OTHER HEALTH ADVOCACY ORGANIZATIONS, ACCESS TO CARE, AND DIVERSITY, EQUITY AND INCLUSION.
ADVOCACY, OUTREACH AND RESEARCH ACTIVITIES:ADVOCACY- ACHA PLAYED A LEADING ROLE IN ADVOCATING FOR THE PASSAGE OF THE CONGENITAL HEART FUTURES ACT IN 2010 AS PART OF THE AFFORDABLE CARE ACT AND FOR THE CONGENITAL HEART FUTURES REAUTHORIZATION ACT (CHFRA) OF 2017. THIS LEGISLATION AUTHORIZES UP TO $10 MILLION ANNUALLY IN FEDERAL FUNDING TO STUDY AND COLLECT DATA ON CONGENITAL HEART DISEASE THROUGH THE U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION, AND IT DIRECTS THE NATIONAL INSTITUTES OF HEALTH TO REPORT ON ONGOING RESEARCH EFFORTS IN CHD. ACHA ANNUALLY ADVOCATES FOR FUNDING CHFRA AT THE HIGHEST AUTHORIZED LEVEL, AND IN FY2023 CONGRESS INCREASED FUNDING FOR THE FIFTH STRAIGHT YEAR, TO $8.25 MILLION (CONTINUED ON SCHEDULE O).ADVOCACY (CONTINUED) - BECAUSE CURRENT AUTHORIZATION REQUIRING CONGRESS TO APPROPRIATE FUNDING FOR CHD RESEARCH AND SURVEILLANCE EXPIRED AT THE END OF 2023, ACHA WILL MOBILIZE THIS YEAR FOR REAUTHORIZATION TO ENSURE CONTINUED SUPPORT FOR PEOPLE WITH CHD. THE CONGENITAL HEART FUTURES REAUTHORIZATION ACT OF 2024 REAFFIRMS OUR COUNTRY'S COMMITMENT TO VITAL RESEARCH, SURVEILLANCE, AND AWARENESS PROGRAMS AT THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) BY REAUTHORIZING FUNDING AT $10 MILLION ANNUALLY THROUGH FY 2029. ACHA WILL SUPPORT CAPITOL HILL VISITS AND IN-DISTRICT VISITS IN 2024 AS WE CONTINUE TO PUSH FOR LEGISLATION AND POLICIES THAT IMPROVE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR CHD PATIENTS. THIS INCLUDES ADDRESSING THE ACHD WORKFORCE SHORTAGE BY IDENTIFYING BARRIERS TO TRAINING NEW FELLOWS TO FOLLOW AN ACHD CAREER PATH. OUTREACH - REGIONAL DEVELOPMENT LEADERS - COVERED TWO REGIONS DURING 2023 TO INCREASE CHD AWARENESS AND DEVELOP CHAMPIONS ACROSS REGIONS.RESEARCH - IN 2023, ACHA FUNDED 3 RESEARCH GRANTS, BRINGING THE TOTAL NUMBER OF GRANTS ISSUED TO 17 AND CLOSE TO $500,000 SINCE 2019.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
James Ruppel MD Ms Chair | OfficerTrustee | 2 | $0 |
Aliza Marlin Vice Chair | OfficerTrustee | 2 | $0 |
Tom Wix Treasurer | OfficerTrustee | 2 | $0 |
Susan Timmins Secretary And Clerk | OfficerTrustee | 2 | $0 |
Stephen Back Board Member | Trustee | 2 | $0 |
Binta Baudy Board Member | Trustee | 2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $27,370 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $2,142,093 |
Noncash contributions included in lines 1a–1f | $15,768 |
Total Revenue from Contributions, Gifts, Grants & Similar | $2,169,463 |
Total Program Service Revenue | $210,517 |
Investment income | $27,716 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,407,696 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $65,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $327,420 |
Compensation of current officers, directors, key employees. | $196,197 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $850,589 |
Pension plan accruals and contributions | $14,024 |
Other employee benefits | $139,368 |
Payroll taxes | $97,575 |
Fees for services: Management | $0 |
Fees for services: Legal | $7,504 |
Fees for services: Accounting | $21,184 |
Fees for services: Lobbying | $25,000 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $132,799 |
Advertising and promotion | $0 |
Office expenses | $98,042 |
Information technology | $80,873 |
Royalties | $0 |
Occupancy | $59,984 |
Travel | $29,262 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $9,220 |
Insurance | $7,021 |
All other expenses | $0 |
Total functional expenses | $1,990,356 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,143,165 |
Savings and temporary cash investments | $1,839 |
Pledges and grants receivable | $76,835 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $23,085 |
Net Land, buildings, and equipment | $11,148 |
Investments—publicly traded securities | $749,920 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $27,241 |
Total assets | $2,033,233 |
Accounts payable and accrued expenses | $72,882 |
Grants payable | $0 |
Deferred revenue | $276,209 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $23,895 |
Total liabilities | $372,986 |
Net assets without donor restrictions | $746,727 |
Net assets with donor restrictions | $913,520 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $2,033,233 |
Over the last fiscal year, Adult Congenital Heart Association Inc has awarded $65,000 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
BAYLOR COLLEGE OF MEDICINE TEXAS CHILDREN'S HOSPITAL PURPOSE: IN SILICO EVALUATION OF A DUAL-IMPELLER SINGLE-DRIVE FONTAN CIRCULATION ASSIST DEVICE | $20,000 |
STANFORD UNIVERSITY PURPOSE: LEVERAGING WEARABLE TECHNOLOGIES FOR ARRHYTHMIA DETECTION IN ADULTS WITH CONGENITAL HEART DISEASE - THE ACHD APPLE WATCH STUDY | $20,000 |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI PURPOSE: INVESTIGATING THE GENES INVOLVED IN PULMONARY ARTERIAL HYPERTENSION IN CONGENITAL HEART DISEASE | $25,000 |